Michael Cloonan
2017
In 2017, Michael Cloonan earned a total compensation of $10M as Chief Business Officer at Sage Therapeutics.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $170,016 |
| Option Awards | $9,439,278 |
| Salary | $301,795 |
| Other | $7,655 |
| Total | $10,043,744 |
Cloonan received $9.4M in option awards, accounting for 94% of the total pay in 2017.
Cloonan also received $125K in bonus, $170K in non-equity incentive plan, $301.8K in salary and $7.7K in other compensation.
Rankings
In 2017, Michael Cloonan's compensation ranked 636th out of 14,666 executives tracked by ExecPay. In other words, Cloonan earned more than 95.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 636 out of 14,666 | 96th |
Division Manufacturing | 209 out of 5,772 | 96th |
Major group Chemicals And Allied Products | 51 out of 2,075 | 98th |
Industry group Drugs | 36 out of 1,731 | 98th |
Industry Pharmaceutical Preparations | 31 out of 1,333 | 98th |
Source: SEC filing on April 27, 2018.
Cloonan's colleagues
We found four more compensation records of executives who worked with Michael Cloonan at Sage Therapeutics in 2017.